603939 益丰药房
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.02815.38315.73913.83015.070
总资产报酬率 ROA (%)1.6176.2526.6265.4846.945
投入资产回报率 ROIC (%)1.9597.6117.9956.4695.589

边际利润分析
销售毛利率 (%)39.24638.20939.52940.34637.981
营业利润率 (%)9.9409.0979.4828.7368.623
息税前利润/营业总收入 (%)10.4049.4029.9689.4799.653
净利润/营业总收入 (%)7.4696.9997.1586.4646.386

收益指标分析
经营活动净收益/利润总额(%)97.16096.763100.03495.72296.011
价值变动净收益/利润总额(%)2.5172.0800.3662.5692.610
营业外收支净额/利润总额(%)-0.048-0.844-0.429-0.072-0.543

偿债能力分析
流动比率 (X)1.2581.0761.0951.1741.306
速动比率 (X)0.9210.7380.7210.7230.936
资产负债率 (%)57.69456.71756.65253.87963.049
带息债务/全部投入资本 (%)41.19439.31638.39433.575--
股东权益/带息债务 (%)116.809125.160129.685154.85991.106
股东权益/负债合计 (%)68.86271.62071.77181.42955.452
利息保障倍数 (X)22.18824.64218.91312.6478.966

营运能力分析
应收账款周转天数 (天)33.87331.73326.43822.3990.000
存货周转天数 (天)93.61095.72299.615102.6270.000